Cover Image
市場調查報告書

市場預測胃癌:主要17個國家

Epiomic Epidemiology Series: Stomach Cancer Forecast in 17 Major Markets 2016-2026

出版商 Black Swan Analysis 商品編碼 353991
出版日期 內容資訊 英文 66 Pages
訂單完成後即時交付
價格
Back to Top
市場預測胃癌:主要17個國家 Epiomic Epidemiology Series: Stomach Cancer Forecast in 17 Major Markets 2016-2026
出版日期: 2016年02月01日 內容資訊: 英文 66 Pages
簡介

本報告提供全球主要17個國家市場上胃癌的病患人口的相關調查,性別、各年齡世代的明細,階段與等級,部位,癌細胞的組織病理學,風險因素,疾病診斷與預後,地區和民族的差異等系統性資訊。

圖表

簡介

病因

風險因素與預防

疾病診斷

各地區/民族的差異

疾病預後和臨床過程

主要的並存症/疾病相關的特徵

定量化患者數的手法

胃癌的患病數top line

胃癌的階段和等級

  • 部位
  • 胃癌的癌細胞的組織病理學
  • 胃癌的Lauren分類
  • 胃癌和幽門螺桿菌感染的並存

簡稱

相關出版

患者為基礎的線上資料庫

患者為基礎的產品

價格的線上資料、平台

參考文獻

附錄

調查對象國家

  • 美國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 英國
  • 巴西
  • 日本
  • 加拿大
  • 澳洲
  • 印度
  • 墨西哥
  • 土耳其
  • 南非
  • 沙烏地阿拉伯
  • 阿根廷
  • 俄羅斯

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: STOM0010316

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Stomach Cancer in 17 Major Markets

Stomach cancer is a broad term encompassing tumours arising in the stomach and includes gastric carcinoma which is a malignant epithelial-origin tumour commonly developing after prolonged periods of gastritis. Stomach cancers tend to develop slowly over many years spreading in different ways. Long-term infection of the stomach with Helicobacter pylori may lead to inflammation (known as chronic atrophic gastritis) and pre-cancerous changes to the inner lining of the stomach.

This report provides the current incident population for Stomach Cancer across 17 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Mexico, Turkey, Argentina, Australia, Canada, Russian, Saudi Arabia and South Africa) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the classifications and co-morbidities of Stomach Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main features and co-morbidities associated with Stomach Cancer include:

  • History of stomach polyps or stomach lymphoma
  • Family history of stomach cancer
  • Colorectal cancer
  • Familial adenomatous polyposis
  • BRCA1/BRCA2 mutations
  • Megaloblastic (pernicious) anaemia or being blood type A

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Stomach Cancer's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the incidence of the subdivided types of Stomach Cancer and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Stomach Cancer's incident population.
  • Identify sub-populations within Stomach Cancer which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Stomach Cancer patients.

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key Co-morbid Conditions/ Features Associated with the Disease
  • Methodology for Quantification of Patient Numbers
    • Additional data available on request
  • Top-Line Incidence for Stomach Cancer
  • Stages and Grading of Stomach Cancer
    • Location of Tumour
    • Histopathology of Tumour Cells in Stomach Cancer
    • Lauren Classification of Stomach Cancer
    • Co-morbidity of H. Pylori infection in Stomach Cancer
  • Abbreviations used in the Report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix

List of Tables

  • AJCC Tumour Grading Classification for Stomach Cancer
  • Incidence of Stomach Cancer, total (000s)
  • Incidence of Stomach Cancer, males (000s)
  • Incidence of Stomach Cancer, females (000s)
  • AJCC Stage at diagnosis for Stomach cancer patients, total (000s)
  • Location of tumour cells in Stomach Cancer patients, total (000s)
  • Major histopathological type of Stomach Cancer, total (000s)
  • Lauren Classification of Adenocarcinoma subtypes in SC patients, total (000s)
  • H. Pylori infection in Stomach cancer, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • USA Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • France Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • France Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Germany Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Germany Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Italy Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Italy Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Spain Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Spain Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • United Kingdom Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • United Kingdom Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Brazil Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Brazil Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Japan Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Japan Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • India Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • India Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Mexico Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Mexico Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Turkey Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Turkey Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Argentina Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Argentina Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Australia Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Australia Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Canada Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Canada Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Russia Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Russia Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • Saudi Arabia Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • Saudi Arabia Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
  • South Africa Incidence of Stomach Cancer by 5-yr age cohort, males (000s)
  • South Africa Incidence of Stomach Cancer by 5-yr age cohort, females (000s)
Back to Top